Jump Financial, LLC Avrobio, Inc. Transaction History

Jump Financial, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	BUY	$0.75 - $1.33 $19,575 - $34,713	26,100 New	26,100 $24,000
Q4 2021 Feb 10, 2022	SELL	$3.45 - $6.05 $153,311 - $268,849	-44,438 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$5.53 - $9.28 $245,742 - $412,384	44,438 New	44,438 $248,000
Q1 2021 May 17, 2021	SELL	$10.54 - $19.3 $140,182 - $256,690	-13,300 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$12.79 - $17.1 $170,107 - $227,430	13,300 New	13,300 $185,000

559K

Ticker AVRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,773,900
Description
AVROBIO, Inc., a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose worldwide. Its gene therapies employ hematopoietic stem cells that are collected from patients and modified with a lentiviral vector to insert functional copies of the gene that is defective in the...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.